I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Pielenhofer, Jonas
19
results:
Search for persons
X
Format
Online (19)
Mediatypes
Articles (Online) (6)
OpenAccess-fulltext (12)
Thesis (Online) (1)
Sorted by: Relevance
Sorted by: Year
?
1
Microneedle-enhanced drug delivery: fabrication, characteri..:
Meiser, Sophie Luise
;
Pielenhofer, Jonas
;
Hartmann, Ann-Kathrin
...
Frontiers in Drug Delivery. 4 (2024) - p. , 2024
Link:
https://doi.org/10.3389/..
?
2
Tumor-infiltrating CCR2+ inflammatory monocytes counteract ..:
Bartneck, Joschka
;
Hartmann, Ann-Kathrin
;
Stein, Lara
...
Frontiers in Immunology. 14 (2023) - p. , 2023
Link:
https://doi.org/10.3389/..
?
3
Optimized dithranol-imiquimod-based transcutaneous immuniza..:
Hartmann, Ann-Kathrin
;
Bartneck, Joschka
;
Pielenhofer, Jonas
...
Frontiers in Immunology. 14 (2023) - p. , 2023
Link:
https://doi.org/10.3389/..
?
4
Quality by Design (QbD) Approach for a Nanoparticulate Imiq..:
Pielenhofer, Jonas
;
Meiser, Sophie Luise
;
Gogoll, Karsten
...
Pharmaceutics. 15 (2023) 2 - p. 514 , 2023
Link:
https://doi.org/10.3390/..
?
5
Novel food drug interaction mechanism involving acyclovir, ..:
García, Mauricio A.
;
Hensler, Gönül
;
Al-Gousous, Jozef
...
Drug Metabolism and Pharmacokinetics. 49 (2023) - p. 100491 , 2023
Link:
https://doi.org/10.1016/..
?
6
Current Progress in Particle-Based Systems for Transdermal ..:
Pielenhofer, Jonas
;
Sohl, Julian
;
Windbergs, Maike
..
Frontiers in Immunology. 11 (2020) - p. , 2020
Link:
https://doi.org/10.3389/..
?
7
Quality, safety and efficacy of a novel nanoparticulate imi..:
Pielenhofer, Jonas
http://doi.org/10.25358/openscience-9892. , 2024
Link:
https://openscience.ub.u..
?
8
Quality by design (QbD) approach for a nanoparticulate imiq..:
Pielenhofer, Jonas
;
Meiser, Sophie Luise
;
Gogoll, Karsten
...
http://doi.org/10.25358/openscience-8804. , 2023
Link:
https://openscience.ub.u..
?
9
Optimized dithranol-imiquimod-based transcutaneous immuniza..:
Hartmann, Ann-Kathrin
;
Bartneck, Joschka
;
Pielenhofer, Jonas
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505723/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
10
Tumor-infiltrating CCR2(+) inflammatory monocytes counterac..:
Bartneck, Joschka
;
Hartmann, Ann-Kathrin
;
Stein, Lara
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10577317/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
11
Quality by Design (QbD) Approach for a Nanoparticulate Imiq..:
Pielenhofer, Jonas
;
Meiser, Sophie Luise
;
Gogoll, Karsten
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9965879/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
12
DataSheet_1_Tumor-infiltrating CCR2+ inflammatory monocytes..:
Joschka Bartneck
;
Ann-Kathrin Hartmann
;
Lara Stein
...
doi:10.3389/fimmu.2023.1267866.s001. , 2023
Link:
https://doi.org/10.3389/..
?
13
Quality by Design (QbD) Approach for a Nanoparticulate Imiq..:
Jonas Pielenhofer
;
Sophie Luise Meiser
;
Karsten Gogoll
...
Pharmaceutical Technology, Manufacturing and Devices. , 2023
Link:
https://doi.org/10.3390/..
?
14
Optimized dithranol-imiquimod-based transcutaneous immuniza..:
Ann-Kathrin Hartmann
;
Joschka Bartneck
;
Jonas Pielenhofer
...
https://www.frontiersin.org/articles/10.3389/fimmu.2023.1238861/full. , 2023
Link:
https://doi.org/10.3389/..
?
15
Quality by Design (QbD) Approach for a Nanoparticulate Imiq..:
Jonas Pielenhofer
;
Sophie Luise Meiser
;
Karsten Gogoll
...
https://www.mdpi.com/1999-4923/15/2/514. , 2023
Link:
https://doi.org/10.3390/..
1-15
